Bayer AG Proposes Inter-se Transfer of 11.91% Promoter Stake in Bayer CropScience

NSE

bayercrop

BSE

506285

Bayer AG has proposed to acquire 53,54,030 equity shares (11.91%) of Bayer CropScience Limited from fellow promoter Bayer CropScience AG through an inter-se promoter transfer under the block deal mechanism. The transaction represents an internal restructuring within the promoter group and does not trigger an open offer under SEBI Takeover Regulations.

PRICE-SENSITIVE TRIGGER

Event: Inter-se transfer of promoter shareholding.

Type: Promoter Shareholding Change

Impact: Neutral

Immediate Effect: The promoter group’s aggregate shareholding remains unchanged, while ownership is redistributed among promoter entities.

Key Metrics:

  • Shares proposed to be acquired: 53,54,030
  • Stake being transferred: 11.91%
  • Proposed acquisition date: On or after July 08, 2026
  • 60-day VWAP: â‚¹4,434 per share
  • Bayer AG holding (Before): 37,88,433 shares (8.43%)
  • Bayer AG holding (After): 91,42,463 shares (20.34%)

Highlight:

  • Bayer AG’s individual shareholding will increase from 8.43% to 20.34%, while overall promoter ownership remains unchanged.
What Happened ?

Bayer AG, an existing promoter of Bayer CropScience Limited, has entered into an agreement to acquire up to 53,54,030 equity shares from another promoter entity, Bayer CropScience AG, through a block deal.

The acquisition is structured as an inter-se transfer among promoters, making it exempt from the mandatory open offer requirement under Regulation 10(1)(a)(ii) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Following completion:

  • Bayer AG’s stake will increase from 8.43% to 20.34%.
  • Bayer CropScience AG will exit its direct shareholding.
  • Aggregate promoter group ownership remains unchanged.
Key Details

Transaction Structure:

  • Acquirer: Bayer AG
  • Seller: Bayer CropScience AG
  • Shares proposed for transfer: 53,54,030
  • Percentage of equity capital: 11.91%
  • Proposed execution date: On or after July 08, 2026
  • Transaction mechanism: Block Deal
  • Nature of transaction: Inter-se transfer among promoter entities
  • Open offer exemption available under SEBI Takeover Regulations.

Pricing:

  • The acquisition price will comply with pricing limits prescribed under Regulation 10(1)(a) of the SEBI Takeover Regulations.
  • The 60-trading-day volume weighted average market price (VWAP) is â‚¹4,434 per share.

Note:

  • The transaction is an internal promoter restructuring and does not involve any change in control, management, or total promoter ownership of Bayer CropScience Limited.
Risk Analysis

Summary:

  • Since the transaction is solely an inter-se transfer within the promoter group, it has limited implications for minority shareholders or the company’s operations.

Key Risks:

  • Regulatory and procedural completion of the block deal.
  • Delay in execution beyond the proposed timeline.
  • Market sentiment may temporarily react to promoter stake movement despite no change in control.

Worst Case:

  • If the transaction is delayed or not completed, the promoter shareholding structure remains unchanged without affecting the company’s business operations.

Risk Level: Low

Company Commentary
  • Bayer AG will acquire up to 53,54,030 equity shares from Bayer CropScience AG.
  • The acquisition is an inter-se promoter transfer executed through the block deal mechanism.
  • Bayer AG qualifies for exemption from the mandatory open offer under Regulation 10(1)(a)(ii) of the SEBI Takeover Regulations.
  • The acquisition price will comply with the regulatory pricing framework.

Official Exchange Filing: Bayer CropScience Limited

Support our work by sharing

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top